|
Post by David on Aug 14, 2014 21:44:48 GMT -5
FDA approves donor lung preservation device that may result in more lung transplantsAugust 12, 2014 Today, the U.S. Food and Drug Administration approved the XVIVO Perfusion System (XPS) with STEEN Solution, a device for preserving donated lungs that do not initially meet the standard criteria for lung transplantation but may be transplantable if there is more time to observe and evaluate the organ’s function to determine whether the lung is viable for transplantation.
Lung transplantation is a primary option in the care of patients with end-stage chronic lung diseases, such as chronic obstructive pulmonary disease, cystic fibrosis and idiopathic pulmonary fibrosis. Approximately one in five donated lungs meets the standard criteria for a donor lung and is transplanted into a recipient. In 2012, 1,754 lung transplants were performed in the United States and at the end of that year, 1,616 potential recipients remained on the waiting list.Read more: www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm409488.htm
|
|
|
Post by sandy07 on Aug 14, 2014 23:06:52 GMT -5
Good. At least they are trying to help shorten the list. Thanks for posting.
|
|
|
Post by stoker55 on Aug 18, 2014 12:18:06 GMT -5
Sounds promising.
|
|
|
Post by jim on Aug 19, 2014 5:18:26 GMT -5
Thanks for sharing David. thumbsupde1
|
|